Back
Galectin Therapeutics, Inc. 10K Form
Sell
49
GALT
Galectin Therapeutics, Inc.
Last Price:
$6.31
Seasonality Move:
33.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
| 2023-11-13 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
| 2023-08-14 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
| 2023-05-15 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
| 2022-11-14 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
| 2022-08-15 | 10Q | GALT/Galectin Therapeutics, Inc. Quarterly |
Receive GALT News And Ratings
See the #1 stock for the next 7 days that we like better than GALT
GALT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.95 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.59130 |
|---|---|
| Net Income (TTM): | $-37.3M |
| Gross Margin: | $-37K |
| Return on Equity: | 0% |
| Return on Assets: | -220.83% |
Galectin Therapeutics, Inc. Earnings Forecast
Key Galectin Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 24 years have been positive in 11 years.
Galectin Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GALT |
| CUSIP: | 363225 |
| Website: | galectintherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -0.99 |
|---|---|
| Current Ratio: | 0.09 |
| Quick Ratio: | 0.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GALT Technical Analysis vs Fundamental Analysis
Sell
49
Galectin Therapeutics, Inc. (GALT)
is a Sell
Is Galectin Therapeutics, Inc. a Buy or a Sell?
-
Galectin Therapeutics, Inc. stock is rated a SellThe current Galectin Therapeutics, Inc. [GALT] share price is $6.30. The Score for GALT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.